Dr Rahul Bhargava

Multiple Sclerosis Treatment in India

Bone Marrow Transplant for Multiple Sclerosis

Contact Us

Related Videos :

FAQs :

Early signs include fatigue, muscle weakness, vision problems, and tingling sensations.

Side effects vary but may include mild flu-like symptoms, fatigue, and, in some cases, immune response modulation side effects.

 MS treatment is typically long-term, with the goal of managing symptoms and improving quality of life.

A balanced diet, regular exercise, and stress management play key roles in MS management.

Bone Marrow Transplant for Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic neurological condition where the immune system mistakenly attacks the protective sheath (myelin) covering nerve fibers. This disrupts communication between the brain and the rest of the body, leading to a wide range of physical and cognitive symptoms. India offers world-class MS care at a fraction of global costs, under the supervision of expert neurologists like Dr. Rahul Bhargava.

Multiple Sclerosis (MS) treatment in India typically ranges from $100 to $15,000 USD per year, depending on the chosen therapy, ranging from affordable oral medications to advanced infusions and stem cell therapy. These costs are significantly lower than in Western countries, making India a preferred destination for comprehensive and long-term MS care.

What is Multiple Sclerosis?

Multiple Sclerosis (MS) is a long-term, immune-mediated disorder that affects the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. In people with MS, the immune system mistakenly attacks the myelin sheath—the protective layer surrounding nerve fibers—causing inflammation and damage. This disrupts the transmission of signals between the brain and the rest of the body.

MS is not a one-size-fits-all disease—it manifests in several forms:

  • Relapsing-Remitting MS (RRMS): The most common type, characterized by episodes of new or worsening symptoms (relapses) followed by periods of partial or complete recovery (remissions).
  • Secondary Progressive MS (SPMS): Initially begins as RRMS and eventually transitions into a steadily progressing form without clear relapses.
  • Primary Progressive MS (PPMS): Marked by gradual worsening of symptoms from the beginning, without any initial relapses or remissions.
  • Progressive-Relapsing MS (PRMS): A rare form that progresses from the start but includes acute relapses.

MS is a complex condition, but with early diagnosis and comprehensive care, many patients can manage symptoms and maintain a high quality of life. In India, advances in diagnostics and access to experienced neurologists like Dr. Rahul Bhargava make timely intervention more accessible and effective.

Treatment Options for MS in India

Multiple Sclerosis treatment in India is built around managing the disease progression, minimizing relapses, and improving the patient’s quality of life. Given the diversity of MS symptoms and progression patterns, treatment is tailored to individual needs. The country offers both conventional and advanced therapies, making India a hub for accessible and effective MS management.

1. Disease-Modifying Therapies (DMTs)

DMTs are the cornerstone of MS treatment. They help reduce the frequency and intensity of relapses and delay disability progression. These include:

  • Injectable medications like Interferon beta and Glatiramer acetate.
  • Oral medications such as Fingolimod, Dimethyl fumarate, and Teriflunomide.
  • Infusion-based therapies like Natalizumab and Ocrelizumab, used in more advanced or aggressive MS cases.

India offers both branded and generic versions of these drugs, making long-term treatment more affordable.

2. Symptomatic Management

Patients often require treatments beyond DMTs to manage specific symptoms:

  • Corticosteroids like methylprednisolone are used to manage acute relapses.
  • Plasma Exchange (Plasmapheresis) is used for severe relapses not responsive to steroids.
  • Physical therapy, speech therapy, and occupational therapy help manage fatigue, muscle stiffness, and mobility issues.

3. Stem Cell Therapy

Stem cell therapy is gaining traction as a regenerative approach to repair damaged neural tissues. Although still considered experimental in some parts of the world, selected Indian hospitals offer autologous stem cell therapy for MS at a relatively affordable cost.

Each treatment plan is customized after thorough neurological assessment, MRI imaging, and blood workups.

What is the Cost of MS Treatment in India?

The cost of Multiple Sclerosis treatment in India is highly competitive compared to global standards, offering high-quality care at a fraction of the cost. The total expense depends on the type of treatment, frequency, and duration of therapy, as well as the hospital chosen and the severity of the disease.

Here’s a breakdown of estimated costs:

  • Injectable Disease-Modifying Therapies (DMTs): Ranges from $300 to $700 USD per month. These include Interferon beta and Glatiramer acetate, commonly prescribed for relapsing forms of MS.
  • Oral Medications: Cost between $100 to $500 USD per month. This includes drugs like Fingolimod, Dimethyl fumarate, and Teriflunomide. India also offers cost-effective generic alternatives.
  • Infusion Therapies (e.g., Ocrelizumab, Natalizumab): These advanced treatments range from $10,000 to $15,000 USD annually, depending on the brand and hospital pricing.
  • Plasmapheresis (Plasma Exchange): For patients experiencing severe flare-ups not responsive to steroids, a single session can cost $3,000 to $5,000 USD.
  • Stem Cell Therapy: Offered at select Indian hospitals under clinical supervision, the cost ranges between $4,000 to $8,000 USD for a complete cycle, including cell harvesting and reinfusion.

Why Choose India for MS Treatment?

India has become a global hub for patients seeking high-quality, affordable treatment for complex neurological disorders like Multiple Sclerosis. With world-class hospitals, experienced specialists, and a patient-friendly healthcare ecosystem, India offers unmatched value for international and domestic patients alike.

Key Reasons to Choose India:

  • Affordable Pricing: The overall cost of MS treatment in India is 50–70% lower than in countries like the US, UK, or Germany. From oral medications to advanced therapies like Ocrelizumab and stem cell therapy, the pricing is significantly more accessible without compromising outcomes.
  • Highly Experienced Neurologists: India is home to internationally trained and experienced neurologists like Dr. Rahul Bhargava, who specialize in autoimmune and neurodegenerative disorders. Their expertise ensures accurate diagnosis and evidence-based treatment.
  • State-of-the-Art Infrastructure: Leading hospitals are equipped with cutting-edge tools such as high-resolution MRI, infusion suites for immunotherapies, and neurology rehabilitation units. Institutions like Fortis, Apollo, and Max Healthcare meet global standards in care delivery.
  • Comprehensive Patient Support: International patients benefit from concierge services including visa assistance, airport transfers, interpreters, and customized treatment packages. Many hospitals also offer teleconsultation and follow-up support after patients return home.
  • Focus on Holistic Rehabilitation: In addition to drug therapies, Indian centers provide integrated support through physiotherapy, occupational therapy, and counseling—essential for long-term management of MS.

India’s combination of affordability, advanced care, and personalized service makes it an ideal destination for MS treatment—especially for patients seeking long-term neurological support with compassionate care.

Why Choose Dr. Rahul Bhargava for MS Treatment?

Dr. Rahul Bhargava is a distinguished name in the field of hematology and neurology, known for his compassionate approach and vast experience in treating autoimmune disorders like Multiple Sclerosis. He is one of India’s leading specialists and heads the department at Fortis Memorial Research Institute, Gurugram.

Reasons to Choose Dr. Bhargava:

  • Expertise in Autoimmune Neurology: Extensive experience in treating complex MS cases using DMTs, stem cell therapy, and symptomatic care.
  • Global Recognition: Trained at some of the top institutions globally, bringing international protocols to Indian care.
  • Patient-Centered Care: Offers personalized treatment plans tailored to disease progression and patient lifestyle.
  • Advanced Diagnostic Access: Utilizes cutting-edge imaging and molecular diagnostics for accurate disease monitoring.
  • Support for International Patients: Known for transparent communication, affordability, and excellent outcomes for patients from around the world.

Patients under Dr. Bhargava’s care benefit from comprehensive MS management and compassionate support throughout their journey.

Contact Information and Appointment Booking

To schedule a consultation with Dr. Rahul Bhargava, please contact or book an appointment through our online portal. We are here to support MS patients and their families every step of the way.

 

Contact us

×